doi: 10.1056/NEJM198606053142306.
Antitrust implications of medical technology assessment
- PMID: 3702964
- DOI: 10.1056/NEJM198606053142306
Item in Clipboard
Antitrust implications of medical technology assessment
N Engl J Med.
.
No abstract available
Similar articles
-
Applying antitrust law to collaboration in the production of information: the case of medical technology assessment.Law Contemp Probl. 1988 Spring;51(2):341-79. Law Contemp Probl. 1988. PMID: 10295965 No abstract available.
-
Courts favor personal preferences over technology assessment.Bus Health. 1986 Dec;4(2):57-8. Bus Health. 1986. PMID: 10279590 No abstract available.
-
PPOs and the antitrust laws.Hospitals. 1983 Oct 16;57(20):65-70. Hospitals. 1983. PMID: 6618473 No abstract available.
-
Antitrust and physician payment.N C Med J. 1984 Apr;45(4):227-31. N C Med J. 1984. PMID: 6585668 No abstract available.
-
[Advanced medical care system, highly advanced medical technology assessment system, and investigator-initiated registration-directed clinical trial].Rinsho Ketsueki. 2011 Oct;52(10):1721-6. Rinsho Ketsueki. 2011. PMID: 21971252 Review. Japanese. No abstract available.
Cited by
-
Brave new medicine. Presidential address to the American Society for Clinical Investigation, San Diego, California, 2 May 1987.J Clin Invest. 1987 Oct;80(4):921-7. doi: 10.1172/JCI113183. J Clin Invest. 1987. PMID: 3654980 Free PMC article. No abstract available.
-
Clinical practice guidelines as legal norms.CMAJ. 1993 Mar 15;148(6):905-8. CMAJ. 1993. PMID: 8448704 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
